[1] H. Fairfield, C. Falank, L. Avery, M.R. Reagan, Multiple myeloma in the marrow: pathogenesis and treatments, Ann N Y Acad Sci, 1364 (2016) 32-51.
[2] P. de la Puente, B. Muz, F. Azab, M. Luderer, A.K. Azab, Molecularly targeted therapies in multiple myeloma, Leuk Res Treatment, 2014 (2014) 976567.
[3] V.P. Cokic, O. Mitrovic-Ajtic, B.B. Beleslin-Cokic, D. Markovic, M. Buac, M. Diklic, N. Kraguljac-Kurtovic, S. Damjanovic, P. Milenkovic, M. Gotic, P.K. Raj, Proinflammatory Cytokine IL-6 and JAK-STAT Signaling Pathway in Myeloproliferative Neoplasms, Mediators Inflamm, 2015 (2015) 453020.
[4] D.F. Calvisi, S. Ladu, F. Pinna, M. Frau, M.L. Tomasi, M. Sini, M.M. Simile, P. Bonelli, M.R. Muroni, M.A. Seddaiu, D.S. Lim, F. Feo, R.M. Pascale, SKP2 and CKS1 promote degradation of cell cycle regulators and are associated with hepatocellular carcinoma prognosis, Gastroenterology, 137 (2009) 1816-1826 e1811-1810.
[5] S. Bhattacharya, R.M. Ray, L.R. Johnson, STAT3-mediated transcription of Bcl-2, Mcl-1 and c-IAP2 prevents apoptosis in polyamine-depleted cells, Biochem J, 392 (2005) 335-344.
[6] Y. Okada, T. Watanabe, T. Shoji, K. Taguchi, N. Ogo, A. Asai, Visualization and quantification of dynamic STAT3 homodimerization in living cells using homoFluoppi, Sci Rep, 8 (2018) 2385.
[7] Y.S. Xu, J.J. Liang, Y. Wang, X.J. Zhao, L. Xu, Y.Y. Xu, Q.C. Zou, J.M. Zhang, C.E. Tu, Y.G. Cui, W.H. Sun, C. Huang, J.H. Yang, Y.E. Chin, STAT3 Undergoes Acetylation-dependent Mitochondrial Translocation to Regulate Pyruvate Metabolism, Sci Rep, 6 (2016) 39517.
[8] V.K. Chaugule, H. Walden, Specificity and disease in the ubiquitin system, Biochem Soc Trans, 44 (2016) 212-227.
[9] H. Sun, V. Kapuria, L.F. Peterson, D. Fang, W.G. Bornmann, G. Bartholomeusz, M. Talpaz, N.J. Donato, Bcr-Abl ubiquitination and Usp9x inhibition block kinase signaling and promote CML cell apoptosis, Blood, 117 (2011) 3151-3162.
[10] A. Denuc, A. Bosch-Comas, R. Gonzalez-Duarte, G. Marfany, The UBA-UIM domains of the USP25 regulate the enzyme ubiquitination state and modulate substrate recognition, PLoS One, 4 (2009) e5571.
[11] F. Seif, M. Khoshmirsafa, H. Aazami, M. Mohsenzadegan, G. Sedighi, M. Bahar, The role of JAK-STAT signaling pathway and its regulators in the fate of T helper cells, Cell Commun Signal, 15 (2017) 23.
[12] J. Luo, R. Yan, X. He, J. He, Constitutive activation of STAT3 and cyclin D1 overexpression contribute to proliferation, migration and invasion in gastric cancer cells, Am J Transl Res, 9 (2017) 5671-5677.
[13] D. Iliopoulos, S.A. Jaeger, H.A. Hirsch, M.L. Bulyk, K. Struhl, STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer, Mol Cell, 39 (2010) 493-506.
[14] N. Dolker, M.W. Gorna, L. Sutto, A.S. Torralba, G. Superti-Furga, F.L. Gervasio, The SH2 domain regulates c-Abl kinase activation by a cyclin-like mechanism and remodulation of the hinge motion, PLoS Comput Biol, 10 (2014) e1003863.
[15] J. Sgrignani, M. Garofalo, M. Matkovic, J. Merulla, C.V. Catapano, A. Cavalli, Structural Biology of STAT3 and Its Implications for Anticancer Therapies Development, Int J Mol Sci, 19 (2018).
[16] G. Fischer, M. Rossmann, M. Hyvonen, Alternative modulation of protein-protein interactions by small molecules, Curr Opin Biotech, 35 (2015) 78-85.
[17] T. Shahian, G.M. Lee, A. Lazic, L.A. Arnold, P. Velusamy, C.M. Roels, R.K. Guy, C.S. Craik, Inhibition of a viral enzyme by a small-molecule dimer disruptor, Nat Chem Biol, 5 (2009) 640-646.
[18] P. Filippakopoulos, S. Muller, S. Knapp, SH2 domains: modulators of nonreceptor tyrosine kinase activity, Curr Opin Struc Biol, 19 (2009) 643-649.
[19] F. Marino-Merlo, E. Papaianni, M.A. Medici, B. Macchi, S. Grelli, C. Mosca, C. Borner, A. Mastino, HSV-1-induced activation of NF-kappaB protects U937 monocytic cells against both virus replication and apoptosis, Cell Death Dis, 7 (2016) e2354.
[20] J. Li, Q. Tan, M. Yan, L. Liu, H. Lin, F. Zhao, G. Bao, H. Kong, C. Ge, F. Zhang, T. Yu, J. Li, X. He, M. Yao, miRNA-200c inhibits invasion and metastasis of human non-small cell lung cancer by directly targeting ubiquitin specific peptidase 25, Mol Cancer, 13 (2014) 166.
[21] Z. Yang, S.J. Huo, Y.Z. Shan, H.J. Liu, Y.M. Xua, K. Yao, X.W. Li, X.L. Zhang, STAT3 repressed USP7 expression is crucial for colon cancer development, Febs Lett, 586 (2012) 3013-3017.
[22] M.I. Davis, R. Pragani, J.T. Fox, M. Shen, K. Parmar, E.F. Gaudiano, L. Liu, C. Tanega, L. Mcgee, M.D. Hall, C. McKnight, P. Shinn, H. Nelson, D. Chattopadhyay, A.D. D'Andrea, D.S. Auld, L.J. DeLucas, Z.Y. Li, M.B. Boxer, A. Sinneonov, Small Molecule Inhibition of the Ubiquitin-specific Protease USP2 Accelerates cyclin D1 Degradation and Leads to Cell Cycle Arrest in Colorectal Cancer and Mantle Cell Lymphoma Models, J Biol Chem, 291 (2016) 24628-24640.